(Q37733245)

22 August 2017

1 reference

title

Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer (English)

1 reference

inflammatory bowel diseases

22 August 2017

main subject

0 references

0 references

1 reference

2

1 reference

22 August 2017

S Danese

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

19 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

29

1 reference

22 August 2017

issue

23

1 reference

22 August 2017

page(s)

3313-3323

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.109

22 August 2017

exact match

0 references

cites work

Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Directing transition from innate to acquired immunity: defining a role for IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Colon cancer and the immune system: the role of tumor invading T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

TNF-alpha in promotion and progression of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Tumour necrosis factor and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Inflammation and cancer: back to Virchow?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

TGF-beta as a T cell regulator in colitis and colon cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Cancer risk in patients with inflammatory bowel disease: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Serum interleukin-6 levels reflect the disease status of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

31 March 2020

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Role of Toll-like receptors in gastrointestinal malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Increased Susceptibility to Colitis-Associated Cancer of Mice Lacking TIR8, an Inhibitory Member of the Interleukin-1 Receptor Family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Review article: the chemoprevention of colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Inflammation, reproduction, cancer and all that.... The regulation and role of the inducible prostaglandin synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The interface between innate and adaptive immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

IL-6 and Its Soluble Receptor Orchestrate a Temporal Switch in the Pattern of Leukocyte Recruitment Seen during Acute Inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Nuclear factor-kappaB in cancer development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Chemokines and serpentines: the molecular biology of chemokine receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Interleukin-10-deficient mice develop chronic enterocolitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Inflammation: gearing the journey to cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Chemokines--chemotactic cytokines that mediate inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Transforming growth factor-beta induces development of the T(H)17 lineage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The chemokine system: redundancy for robust outputs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Cancer-related inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Tuning inflammation and immunity by chemokine sequestration: decoys and more

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Macrophage polarization comes of age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The molecular biology of leukocyte chemoattractant receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

NF-kappaB and cancer-identifying targets and mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Promotion of colorectal neoplasia in experimental murine ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Predominant T helper type 2-inflammatory responses promote murine colon cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

IKK/NF-kappaB signaling in intestinal epithelial cells controls immune homeostasis in the gut.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Possible mode of action of 5-aminosalicylic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Toll-like receptors and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Oxidative stress in ulcerative colitis-associated carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Role of cyclooxygenase-2 in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Molecular basis of the potential of mesalazine to prevent colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Tumour necrosis factor-alpha as a tumour promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Immunogenic death of colon cancer cells treated with oxaliplatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

31 March 2020

Tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.109

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.109

1 reference

Dimensions Publication ID

22 August 2017

1004150473

0 references

1 reference